Nightingale Health Oyj
NGHLF
$1.75
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.40M | 1.41M | 1.35M | 1.25M | 1.23M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.40M | 1.41M | 1.35M | 1.25M | 1.23M |
| Cost of Revenue | 486.00K | 488.10K | 414.20K | 384.10K | 226.50K |
| Gross Profit | 916.70K | 920.70K | 939.20K | 870.80K | 1.00M |
| SG&A Expenses | 2.39M | 2.40M | 2.61M | 2.42M | 2.13M |
| Depreciation & Amortization | 2.00M | 2.01M | 2.21M | 2.04M | 2.35M |
| Other Operating Expenses | 1.63M | 1.64M | 1.94M | 1.80M | 1.39M |
| Total Operating Expenses | 6.51M | 6.53M | 7.18M | 6.65M | 6.09M |
| Operating Income | -5.10M | -5.12M | -5.82M | -5.40M | -4.86M |
| Income Before Tax | -5.13M | -5.15M | -5.79M | -5.37M | -4.37M |
| Income Tax Expenses | -2.30K | -2.30K | 27.80K | 25.80K | 2.10K |
| Earnings from Continuing Operations | -5.13M | -5.15M | -5.82M | -5.40M | -4.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.13M | -5.15M | -5.82M | -5.40M | -4.37M |
| EBIT | -5.10M | -5.12M | -5.82M | -5.40M | -4.86M |
| EBITDA | -3.81M | -3.83M | -4.52M | -4.19M | -2.51M |
| EPS Basic | -0.08 | -0.08 | -0.10 | -0.09 | -0.07 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.06 | -0.06 | -0.04 |
| EPS Diluted | -0.08 | -0.08 | -0.10 | -0.09 | -0.07 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.06 | -0.06 | -0.04 |
| Average Basic Shares Outstanding | 60.94M | 60.94M | 59.77M | 59.77M | 60.92M |
| Average Diluted Shares Outstanding | 60.94M | 60.94M | 59.77M | 59.77M | 60.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |